SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-127981
Filing Date
2023-12-21
Accepted
2023-12-21 08:30:40
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 tm2333068-1_s3.htm S-3 520674
2 EXHIBIT 1.2 tm2333068d2_ex1-2.htm EX-1.2 254474
3 EXHIBIT 5.1 tm2333068d2_ex5-1.htm EX-5.1 39789
4 EXHIBIT 5.2 tm2333068d2_ex5-2.htm EX-5.2 25708
5 EXHIBIT 23.3 tm2333068d2_ex23-3.htm EX-23.3 2367
6 EX-FILING FEES tm2333068d2_ex-filingfees.htm EX-FILING FEES 41094
7 GRAPHIC tm2333068d2_ex5-1img01.jpg GRAPHIC 2773
8 GRAPHIC tm2333068d2_ex5-2img01.jpg GRAPHIC 3463
9 GRAPHIC tm2333068d2_ex5-2img02.jpg GRAPHIC 2583
10 GRAPHIC lg_meiragtx-4c.jpg GRAPHIC 11631
  Complete submission text file 0001104659-23-127981.txt   913972
Mailing Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016 6464902965
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276183 | Film No.: 231502881
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)